Designed to support and enhance brain function

CHICAGO, IL / ACCESSWIRE / March 31, 2022 / Cosmos Holdings, Inc. ("the Company") (NASDAQ:COSM), an international pharmaceutical company with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices, announced today that Sky Premium Life, Cosmos' proprietary luxury nutritional supplement product line, has launched Brainlit for brain health.

Cosmos' R&D team has developed an advanced formula that is designed to support and enhance brain function. Brain-related conditions such as Alzheimer's and other forms of dementia, Parkinson's, depression and anxiety have been on the rise in recent years, and yet there is a significant unmet need for effective treatment options. The World Health Organization (WHO) published in September 2021 that more than 55 million people live with dementia worldwide, and there are nearly 10 million new cases every year.

The global market size for brain health supplements was estimated to be approximately $7.7 billion in 2020, and is anticipated to reach $19.7 billion by 2030. The rise in the geriatric population is expected to drive growth in the brain health supplement market.

"With the global population aging, there is increased demand for high-quality brain health supplements that can enhance memory, improve brain function and health," commented, Greg Siokas, Chief Executive Officer of Cosmos Holdings. "We also believe that the lingering effects of COVID-19 ("long-haulers") and stress the pandemic has placed on society, will further contribute to growth in the overall brain health supplements market. Notably, more and more people are flocking to nutritional supplements to remain healthy, boost their immunity and enhance their brain function. Our goal is to provide consumers with products that have a positive effect on their daily lives and each Sky Premium Life formula is designed to meet those objectives. We continue to invest in our R&D initiatives, as we are constantly designing new formulas to meet evolving health demand, while ensuring the highest quality products and continually enhancing our manufacturing processes."

The Brainlit supplement is made with the highest quality raw materials and includes ginkgo biloba, glutamine and L-tyrosine and other vitamins and minerals essential for brain function. According to recent studies, ginkgo biloba leaf extract may enhance a number of cognitive processes, such as memory, processing speed, concentration and focus. The other two substances used in the product are the amino acids, glutamine and L-tyrosine. Glutamine plays a critical role in the normal functioning of the brain, while tyrosine supports production of the neurotransmitter's dopamine and norepinephrine. The formula also includes iron and vitamin B5 intended to reduce fatigue, as well as vitamins C, B6, and B12 intended to improve the normal functioning of the nervous system.

Cosmos Holdings Inc. (Nasdaq:COSM) is an international pharmaceutical company, with a proprietary line of nutraceuticals and distributor of branded and generic pharmaceuticals, nutraceuticals, OTC medications and medical devices through an extensive, established EU distribution network. The Company identifies, acquires, develops and commercializes products that improve patients' lives and outcomes and has developed a global distribution platform and is currently expanding throughout Europe, Asia and North America. Cosmos Holdings has offices and distribution centers in Thessaloniki, Greece, Athens, Greece and Harlow, UK. More information is available at www.cosmosholdingsinc.com and www.skypremiumlife.com.

With the exception of the historical information contained in this news release, the matters described herein, may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements preceded by, followed by, or that otherwise, include the words "believes," "expects," "anticipates," "intends," "projects," "estimates," "plans" and similar expressions or future or conditional verbs such as "will," "should," "would," "may" and "could", are generally forward-looking in nature and not historical facts, although not all forward-looking statements include the foregoing. These statements, involve unknown risks and uncertainties that may individually or materially impact the matters discussed, herein for a variety of reasons that are outside the control of the Company, including, but not limited to, the Company's ability to raise sufficient financing to implement its business plan, the impact of the COVID-19 pandemic on the Company's business, operations and the economy in general, and the Company's ability to successfully develop and commercialize its proprietary products and technologies. Readers are cautioned not to place undue reliance on these forward- looking statements, as actual results could differ materially from those described in the forward-looking statements contained herein. Readers are urged to read the risk factors set forth in the Company's filings with the SEC, which are available at the SEC's website (www.sec.gov). The Company disclaims any intention or obligation to update, or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Investor Relations Contact: Crescendo Communications, LLC Tel: 212-671-1020 Email: COSM@crescendo-ir.com

View source version on accesswire.com: https://www.accesswire.com/695455/Cosmos-Holdings-Launches-Proprietary-Sky-Premium-Life-Brainlit-Supplement-for-Brain-Health

FEATURE Tesla CEO Elon Musk is irked at Bill Gates. He doesn’t see how Gates, a leading proponent of sustainable energy, could possibly sell Tesla stock short. And Musk says Gates is doing just that.

(Bloomberg) -- Fears about the economic toll of China’s strict Covid Zero policy intensified Monday, as news that lockdowns were spreading to Beijing sent stocks, commodities and the yuan tumbling. Most Read from BloombergUkraine Latest: Zelenskiy Says Top U.S. Officials to Visit KyivUkraine Latest: U.S. Vows to Step Up Arms, Diplomacy in KyivNew Texts Shed Light on Elon Musk’s 2018 Spat With Saudi FundMacron Beats Le Pen to Win Second Term as French PresidentDisney’s $578 Million Tax Break Left

After sharp losses Friday, Wall Street is poised for more declines as stock-index futures slid Sunday night.

The Fed clobbered stocks, with the S&P 500 and Nasdaq Composite down for the third straight week, and the Dow Jones Industrial Average notching its fourth straight losing week.

The once-highflying group of Big Tech names has disappointed—or worse—this year, with one exception. Investors are awaiting Apple’s earnings this coming week with more trepidation than usual.

Twitter's fate may be hanging in the balance. No longer is the description "chief executive officer" or "chief financial officer" enough to indicate power, prestige and hierarchical standing. Elon Musk -- of course -- got the thing started last year when he officially changed his title at Tesla as well as that of the EV maker's chief financial officer.

Stock-market downturns early in retirement often harm the durability of savings, but they can give retirees willing to do some research and steel their nerves an opportunity to juice longer-term returns

A big dividend yield can be a red flag and portend trouble for a company. But due diligence can lead investors to some solid companies with yields in the 5% neighborhood.

The major indexes and leading stocks suffered serious losses yet again. Twitter is warming to Tesla CEO Elon Musk's bid.

The stock market ended a volatile week on a gloomy note Friday, with the three major U.S. indexes plunging as investors got tripped up in worries like inflation and the Fed’s fight against it and fears of a hard-landing recession.

Anderson, a partner at Baillie Gifford, is one of the preeminent growth-stock investors of his time. As he prepares to step down, he’s more optimistic than ever.

(Bloomberg) -- Stocks, U.S. futures and commodities sank with Treasury yields Monday as China’s worsening Covid situation amplified concerns about a slowdown in demand in the world’s second-largest economy.Most Read from BloombergUkraine Latest: Zelenskiy Says Top U.S. Officials to Visit KyivUkraine Latest: U.S. Vows to Step Up Arms, Diplomacy in KyivNew Texts Shed Light on Elon Musk’s 2018 Spat With Saudi FundMacron Beats Le Pen to Win Second Term as French PresidentDisney’s $578 Million Tax Br

This week, 165 S&P 500 companies, or about a third of the S 500, and nearly half the Dow Jones Industrial Average are scheduled to report earnings.

Chinese regulators hinted they may allow U.S. audits of U.S.-listed China stocks, but Covid lockdowns hit much of the economy.

Asian shares declined Monday after U.S. stocks ended last week on a tumble as global markets' expectations for higher interest rates continued to set the tone.

First-quarter earnings season ramps up with results from Big Tech companies Alphabet, Microsoft, Meta Platforms, Amazon.com, and Apple. Plus, first-quarter GDP data and more.

(Bloomberg) -- Anthony Scaramucci, whose curiosity about cryptocurrencies began during his short stint in Washington, now plans to pivot his SkyBridge Capital toward digital assets after years of focusing on high-profile hedge funds.Most Read from BloombergUkraine Latest: Zelenskiy Says Top U.S. Officials to Visit KyivUkraine Latest: U.S. Vows to Step Up Arms, Diplomacy in KyivNew Texts Shed Light on Elon Musk’s 2018 Spat With Saudi FundMacron Beats Le Pen to Win Second Term as French PresidentD

Retirement Systems of Alabama slashed an investment in GM and sold Nvidia stock in the first quarter while buying up Ford and Intel.

(Bloomberg) -- Value investing is winning again, after famously lagging since the global financial crisis, as rising bond yields stifle technology stocks anew -- while the lost decade for emerging markets is far from over.Most Read from BloombergUkraine Latest: Zelenskiy Says Top U.S. Officials to Visit KyivUkraine Latest: U.S. Vows to Step Up Arms, Diplomacy in KyivNew Texts Shed Light on Elon Musk’s 2018 Spat With Saudi FundMacron Beats Le Pen to Win Second Term as French PresidentDisney’s $57

(Reuters) -Twitter Inc kicked off deal negotiations with Elon Musk on Sunday after he wooed many of the social media company's shareholders with financing details on his $43 billion acquisition offer, people familiar with the matter said. The company's decision to engage with Musk, taken earlier on Sunday, does not mean that it will accept his $54.20 per share bid, the sources said. It signifies, however, that Twitter is now exploring whether a sale of the company to Musk is possible on attractive terms, the sources added.